Zhaohui Ni, Renhua Lu, Xudong Xu, Xueyan Bian, Zhihong Zhou, Junwei Yang, Qun Luo, Menghua Chen, Chaosheng Chen, Xiuli Sun, Lei Yu, Qiang He, Hong Jiang, Weijie Yuan, Yi Li, Rong Zhou, Jianqin Wang, Xinzhou Zhang, Li Zuo, Xiangwen Meng, Zhiren Chang, June Zhao, Peter Wessman, Peng Xiang
PURPOSE: The DIALIZE China study (Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese Subjects) (NCT04217590) evaluated sodium zirconium cyclosilicate (SZC) for the management of hyperkalemia in Chinese patients undergoing hemodialysis. METHODS: In the double-blind, Phase IIIb DIALIZE China study, Chinese adults with kidney failure and predialysis hyperkalemia (predialysis serum potassium [sK+ ] concentration >5.4 mmol/L after the long interdialytic interval [LIDI] and >5...
June 27, 2023: Clinical Therapeutics